9 articles with SIRION Biotech
SIRION Biotech GmbH announced its participation in major international conferences this October.
Gene and Cell Therapy Solutions Provider, SIRION Biotech Announces Record First Half 2019 Financial Results
Viral Vector Engineer Gains Momentum from its Technology, LentiBoost™ with 100% Growth
4/18/2019In the first quarter of 2019, more than 30 life science companies* announced expansions, new locations, increased funding, new trial and product launches and various other news pointing to a growing industry.
Sirion Biotech International threw a Bavarian-themed grand opening party at the Forsythe Institute on Feb. 1. The new headquarters are in Cambridge, Mass and currently have five employees.
Europe’s Leading Commercial Provider of Viral Vector Technology Opens Local Office in Cambridge
SIRION Biotech Plans Path for U.S. Market Expansion
SIRION Biotech Release: Tissue Specific Optimized AAV Plasmids Are Now Available To Make Research & Therapy More Targeted
SIRION Biotech Participates In Gene Therapy Expert Panel Discussion At The Piper Jaffray GenomeRx Symposium